18 June 2013
Keywords: astrazeneca, initiates, ph, iii, comparison, zactima, tarceva
Article | 09 October 2006
Anglo-Swedish drug major AstraZeneca says it has initiated a Phase III trial comparing its anticancer agent Zactima (ZD6474) with Roche's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 2006
27 November 2006
20 November 2006
© 2013 thepharmaletter.com